Pharmacological inhibition of Piezo1, TRPV4 and phospholipase A2 as well as knock out of both channels in mice have shown a protection against AP hallmarks suggesting these novel molecular targets could be highly important in future pressure-induced AP treatment. This evidence concerns the gene TRPV4 and alkaline phosphatase measurement.